Predictors of the efficacy of metformin in polycystic ovary syndrome
- Authors: Naidukova A.A1, Ananyev E.V1, Donnikov A.E.1, Chernukha G.E1
-
Affiliations:
- Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Issue: No 11 (2017)
- Pages: 69-76
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248073
- DOI: https://doi.org/10.18565/aig.2017.11.69-76
- ID: 248073
Cite item
Abstract
Full Text
About the authors
A. A Naidukova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: aleeshka@mail.ru
post-graduate student, Department of Gynecological Endocrinology
E. V Ananyev
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: new_vision@mail.ru
head of the 2nd maternity ward
Andrey Evgenyevich Donnikov
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_donnikov@oparina4.ru
PhD, senior staff scientist of laboratory of molecular genetic methods
G. E Chernukha
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: c-galina1@yandex.ru
head of the Department of Gynecological Endocrinology
References
- Fauser B.C., Tarlatzis B.C., Rebar R.W., Legro R.S., Balen A.H., Lobo R. et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 2012; 97(1): 28-38. e25. doi: 10.1016/j.fertnstert.2011.09.024.
- Kurzthaler D., Hadziomerovic-Pekic D., Wildt L., Seeber B.E. Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects. Reprod. Biol. Endocrinol. 2014; 12: 98. doi: 10.1186/1477-7827-12-98.
- Diamanti-Kandarakis E., Christakou C.D., Kandaraki E., Economou F.N. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur. J. Endocrinol. 2010; 162(2): 193-212.
- Legro R.S., Arslanian S.A., Ehrmann D.A., Hoeger K.M., Murad M.H., Pasquali R., Welt C.K.; Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2013; 98(12): 4565-92. doi: 10.1210/jc.2013-2350.
- Balen A.H., Morley L.C., Misso M., Franks S., Legro R.S., Wijeyaratne C.N. et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum. Reprod. Update. 2016; 22(6): 687-708.
- Jean Hailes Foundation for Women’s Health. Evidence-based guideline for the assessment and management of polycystic ovary syndrome. Developer 2011. Updated August 2015.
- Байдукова А.А., Ананьев Е.В., Чернуха Г.Е. Влияние метформина на репродуктивную функцию женщин с различными фенотипами СПКЯ. Акушерство и гинекология. 2017; 10: 55-61. https://dx.doi.org/10.18565/ aig.2017.10.55-61 [Naidukova A.A., Ananyev E.V., Chernukha G.E. Effect of metformin on the reproductive function of women with different phenotypes of polycystic ovary syndrome. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (10): 55-61. (in Russian) https://dx.doi.org/10.18565/ aig.2017.10.55-61]
- Hosseini M.A., Alleyassin A., Sarvi F., Safdarian L., Kokab A., Fanisalek M. Metformin treatment in different phenotypes of polycystic ovary syndrome. Arch. Gynecol. Obstet. 2013; 288(5): 1131-6. doi: 10.1007/s00404-013-2800-5.
- Palomba S., Falbo A., Russo T., Manguso F., Tolino A., Zullo F. et al. Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2007; 92(8): 3128-35.
- Fleming R., Hopkinson Z.E., Wallace A.M., Greer I.A., Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J. Clin. Endocrinol. Metab. 2002; 87(2): 569-74.
- Mahran A., Abdelmeged A., El-Adawy A.R., Eissa M.K., Shaw R.W., Amer S.A. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study. J. Clin. Endocrinol. Metab. 2013; 98(10): 4170-5.
- Neagu M., Cristescu C. Anti-Müllerian hormone - a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome. J. Med. Life. 2012; 5(4): 462-4.
- Vanky E., Stridsklev S., Heimstad R., Romundstad P., Skogøy K., Kleggetveit O. et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J. Clin. Endocrinol. Metab. 2010; 95(12): E448-55.
- Welt C.K., Pau C.T., Keefe C., Duran J. Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study. J. Clin. Endocrinol. Metab. 2014; 99(5): 1870-8. doi: 10.1210/jc.2013-4021.
- Conway G., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Franks S., Gambineri A. et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur. J. Endocrinol. 2014; 171(4): P1-P29.